Formulations 2020

Jun 22-23, 2020

|

Chicago, United States of America

Formulations and Drug Delivery Forum

Do you want to learn the advanced technologies in Pharmaceutical Formulations and Drug Delivery?

Come and join us at “Formulations and Drug Delivery Forum” scheduled during June 22-23, 2020 at Chicago, USA.

The main theme of this Pharma conference is “Vision to Reality- Delivering Next Generation Pharmaceutical Technologies” which covers a wide range of critically important sessions

Formulations 2020 is designed to provide a strong platform for Academic, Industrial Leaders, Business and Financial Executives to make experience exchanges around the world. This is an excellent opportunity for the delegates from Universities and Institutes to interact with the world class Scientists.

The event offers a best platform with its well organized scientific program to the audience which includes interactive panel discussions, keynote lectures, plenary talks and poster Sessions.

The pharmaceutical industry is emerging at an unusually rapid pace. Industrial companies are challenged with enormous tasks due to high market growth, new medicines and therapy forms, changing regulations and progressing digitization.

It is believed that the expenses for drugs will amount to 1.5 trillion U.S. dollars globally in 2021. The global blow fill seal technology market was esteemed at USD 278.1 million in 2017 and is probable to reach USD 386.0 million by 2023, at a CAGR of 5.71%.

The topical drug delivery market is anticipated to reach USD 125.88 Billion by 2021 from USD 92.40 Billion in 2016 at a CAGR of 6.4% during the forecast period.

Lucy
Harish Padh
Director
PERD Centre

Biography

He has completed his Ph.D from Delhi University and postdoctoral studies from Temple University, Philadelphia, He has been Professor of Biochemistry at M. S. University of Baroda, Director of PERD Center, and Project Director for NIPER.

Researches :

  • His area of research is Cell and Molecular Biology as applied to Health and Pharmaceutical Sciences. He has more than 170 research publications in reputed journals. He has more than 5900 citations; cumulative Impact Factor: 280; h-Index: 39; i10-Index: 82.
Lucy
Dr kaliappanadar Nellaiappan
Director, product development
CuriRx, Inc

Biography

Dr. Kaliappanadar Nellaiappan has more than 25 years of experience in the development of new drugs and therapeutic agents. He has led various teams to develop more than 100 dosage formulations throughout his career and continues to head a product developm

Researches :

  • He has also been involved in developing novel drug delivery systems for both hydrophobic and hydrophilic molecules, including peptides, and polymer-based oral nanoparticles. He has seven approved patents, several patent applications pending, and more than 50 publications to his name. Dr. Nellaiappan received Royal Society bursary award from Oxford University.
Lucy
Gamze Guney Eskiler
Doctor of Medicine
Medical Biology Unit
Sakarya University School of Medicine

Biography

She has completed her Ph.D from Uludag University, Turkey. Her thesis received “2017 Uludag University the best Ph.D thesis in Institute of Health science” and “Higher Education Institution 2018 Outstanding Achievement Health Sciences Individual Award”.

Researches :

  • She has published more than 25 papers in reputed journals and presented more than 40 papers in international conferences. She also received different scientific awards from different international conferences. Her research interests focus on cancer, drug resistance mechanisms, nanoparticle based drug delivery systems, cell death types and pathways and combine treatment strategies in cancer.
Lucy
Dr Saad Maria Alshahrani
Assistant Professor
Head of Pharmaceutical Sciences Department
Prince Sattam bin Abdulaziz University,

Biography

Saad Alshahrani has completed his Ph.D at 2015 from the college of pharmacy at the University of Mississippi in USA. He is the head department of pharmaceutics in college of pharmacy, Prince Sattam bin Abdulaziz University, KSA. Dr. Alshahrani is a licens

Researches :

  • His current research focuses in nanotechnology and advance drug delivery. He participated in several conferences as a speaker and published several research articles.
Lucy
Dr Sandhya S
Professor and Head of Department
Department of Pharmacognosy
St James Medical Academy

Biography

Dr Sandhya S has completed her Ph.D at the age of 40 years from Acharya Nagarjuna University, Guntur, Andhra Pradesh and is the recepeint of two prestigious awards Dr APJ Abdul Kalam best scientist award by Bose Science Society, TNSRO, Tamil Nadu and 5th

Researches :

  • She is an approved Ph.D guide under KUHS and has evaluated several Ph.D thesis of research scholars. She has guided several UG and PG projects. She has published more than 112 papers in national as well as internationally reputed journals. She is serving as the editorial board member of Hygeia-Journal Drugs and Medicine, Indian Journal of Natural Science and International journal of innovative research. She has reviewed several papers and is in the review committee of reputed journals like Journal of Chinese integrative medicine, Journal of Medicinal Plant research, Journal of Herbs, Spices and Medicinal Plants, BMC Complementary and Alternative Medicine etc.
Lucy
Guangqing Xiao
Director
Sunovion Pharmaceuticals Inc

Biography

Guangqing Xiao has completed his Ph.D from Boston University and postdoctoral studies from University of California at San Francisco, School of Pharmacy. He is the director of DMPK at Sunovion Pharmaceuticals Inc.

Researches :

  • He has published more than 25 papers in reputed journals and repute. A highly motivated, well-organized, and technically proficient scientist with over fifteen year’s experience in drug discovery and development. Experience in ADME, DDI, PK/PD modeling using Phoenix & SimCYP, human PK & dose projection for both small molecules and biologics. Ph.D. in Biochemistry & Cell Biology, and Postdoctoral training in drug transporters.
Lucy
Dr tvs Zsolt
Senior Scientist
NanGenex Inc

Biography

Dr. Ötvös is Senior Scientist at NanGenex Inc. He graduated as chemist and completed his PhD in environmental sciences at the University of Szeged. Before joining NanGenex Inc,

Researches :

  • He held research fellow position at the Chemical Research Center of the Hungarian Academy of Sciences. He is co-author of 13 research papers and presented his work at numerous international conferences.

Program Overview

Our Collaborations, Sponsors, Media Partners